Skip to content

Study · Non-randomized trial · n = 81 · 2023

1 result

[Developmental outcomes of very preterm and extremely preterm infants at the 12 months corrected age].

Yakovenko MP, Kleshenko EI, Kayumova DA

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova1 Jan 2023

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In preterm infants with pyramidal tract damage, normal neurodevelopment was more frequent with Cortexin plus rehabilitation than rehabilitation alone.

    In plain wordsPreterm infants with pyramidal tract damage had normal development more often with Cortexin plus rehabilitation than rehabilitation alone.

    Outcome
    IncreaseNormal neurodevelopment at corrected age
    Study

    n = 81

    Comparator
    Non-drug rehabilitation alone in infants with pyramidal tract damage
    Outcome group
    Cell proliferation and differentiation · Nervous system and cognition
    Studied dose
    Dose not stated · first yearAs given in this study (human).

    Measurements

    Normal neurodevelopment
    40.7%
    Cortexin plus rehabilitation
    Normal neurodevelopment
    18.2%
    rehabilitation alone

    Source sentences

    Summary
    The results showed that at the correct age of 12 months normal neurodevelopment occurred more often in two times in second group (1 group - 18.2%, 2 group - 40.7%, p<0.05).
    3 context sentences
    Summary · context
    I group - 22 infant with damage to the PT, treating non-drug rehabilitation during the first year.
    Summary · context
    II group - 59 infant with damage to the PT, treating non-drug rehabilitation and Cortexin during the first year.
    Summary · context
    Neurodevelopmental outcomes was evaluated by using the INFANIB scale at the 12 months corrected age.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:25 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.